SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharma trades in green on the bourses

20 Dec 2018 Evaluate

Alembic Pharmaceuticals is currently trading at Rs 607.50, up by 10.70 points or 1.79% from its previous closing of Rs 596.80 on the BSE.

The scrip opened at Rs 606.65 and has touched a high and low of Rs 621.35 and Rs 606.65 respectively. So far 9877 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 664.00 on 27-Sep-2018 and a 52 week low of Rs 412.40 on 24-May-2018.

Last one week high and low of the scrip stood at Rs 619.95 and Rs 594.00 respectively. The current market cap of the company is Rs 11622.95 crore.

The promoters holding in the company stood at 72.96%, while Institutions and Non-Institutions held 14.88% and 12.16% respectively.

United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' API Facility located at Panelav in the state of Gujarat from December 17 - 19, 2018. This was a scheduled inspection and at the end of the inspection, there were zero 483s.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

763.95 0.40 (0.05%)
22-Apr-2026 15:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.70
Dr. Reddys Lab 1218.00
Cipla 1235.40
Zydus Lifesciences 930.80
Lupin 2304.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×